Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Rubius Therapeutics (RUBY) hired Dannielle Appelhans as chief operating officer. Most recently, she was senior vice president of technical operations and chief technical officer at the gene therapies unit at Novartis (NVS).
Create a display name to comment
This name will appear with your comment